Intouch Solutions

SEPTEMBER 27, 2024

The discourse wasn’t just about cycling through tissue or aiding clinical development; it ranged from mutation prediction to tumor microenvironment (TME) analysis to how AI can aid in diagnosis and treatment planning to achieve better outcomes for patients. It may, you know, impact their role and their day-to-day functions.

DNA 59

DNA Trials Antibody Marketing 59

XTalks

JANUARY 19, 2024

Advantages of Alpha Emitter Therapy Over the past two decades, the radiological and chemical properties of alpha emitting isotopes have regained prominence in medical physics. Alpha particle therapy represents a significant advancement in cancer treatment, reflecting the growing trend in oncology towards personalized and precision medicine.

DNA 66

DNA Radiology FDA Approval Development 66

The Pharma Data

DECEMBER 8, 2020

It is characterized by progressive fibrosis, lung scarring, and a radiological pattern known as usual interstitial pneumonia, or UIP. Idiopathic pulmonary fibrosis, or IPF, is a serious, chronic, progressive, fibrosing interstitial pneumonia with no known cause; typically occurring in patients above 50 years of age.

Drugs 40

Drugs FDA Approval Marketing Containment 40

The Pharma Data

MARCH 17, 2021

Symptoms may include hypoxia, cough, dyspnea, or interstitial infiltrates on radiologic exams. Dose interruption or dose reduction is recommended in patients who develop persistent or recurrent Grade 2 ILD/pneumonitis. Across the clinical development program, deaths due to venous thromboembolism have been reported.

HR 52

HR Trials In-Vitro Manufacturing 52

XTalks

SEPTEMBER 11, 2024

Jansen recently moderated a webinar in which her colleagues at Medpace discussed the evolving women’s health sector, including the historical challenges and emerging trends in clinical development. A thorough analysis of the disease’s complexity, including pathophysiology, natural history and treatment landscape, is essential.

Clinical Trials 103

Clinical Trials Clinical Trials Trials Hormones 103

The Pharma Data

MARCH 29, 2022

AstraZeneca AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. W911QY-21-9-0001.

Antibody 52

Antibody In-Vivo Vaccine Vaccination 52

The Pharma Data

MAY 3, 2021

Sandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine ( Press ). Radiology Partners, Aidoc talk AI adoption, handling bias, FDA actions ( MedtechDive ). . UK Could Become ‘World Leader’ On Biosimilar Regulation ( Pink Sheet ).

Gene Therapy 52

Gene Therapy Vaccine Vaccination Bioequivalency 52

XTalks

SEPTEMBER 14, 2020

Below are some free webinars you can register for that have delved into the topic: Continuing Clinical Research Innovations After COVID-19. The Impact of COVID-19 on Early Clinical Development – What the New Landscape Will Look Like. Addressing the Rapidly Evolving Vaccine Development Landscape. Drugs and Vaccines.

Vaccine 92

Vaccine Vaccination Antibody Life Science 92